Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 3 4 Next Page Last Page
 
1
Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.
1992-11-01

Decay-accelerating-factor (DAF, CD55), a phosphatidyl-inositol anchored glycoprotein, is a member of the cell membrane bound complement regulatory proteins that inhibit autologous complement cascade activation. DAF was found expressed on cells that are in close contact with serum complement proteins, but also on cells outside the ...

PubMed Central

2
The complement regulatory proteins CD55 (decay accelerating factor) and CD59 are expressed on the inner acrosomal membrane of human spermatozoa as well as CD46 (membrane cofactor protein)
2006-07-01

The complement regulatory proteins CD55 and CD59 are expressed on the plasma membrane of human spermatozoa, whereas CD46 is only on the inner acrosomal membrane (IAM) which becomes surfaced exposed after the acrosome reaction when sperm assume fertilisation-competence. CD55 & CD59, two ...

PubMed Central

3
Human Diffusely Adhering Escherichia coli Expressing Afa/Dr Adhesins That Use Human CD55 (Decay-Accelerating Factor) as a Receptor Does Not Bind the Rodent and Pig Analogues of CD55
2004-08-01

Afa/Dr diffusely adhering Escherichia coli (DAEC) bacteria that are responsible for recurrent urinary tract and gastrointestinal infections recognized as a receptor the glycosylphosphatidylinositol (GPI)-anchored protein decay-accelerating factor (DAF; CD55) at the brush border of cultured human intestinal cells. ...

PubMed Central

4
CD55 and CD59 protein expression by Apodemus (field mice) sperm in the absence of CD46.
2009-06-05

The mammalian female reproductive tract has an abundance of complement components, which play a vital role in protection against genital pathogens. Sperm may be protected against complement-mediated damage by complement regulatory proteins, including membrane cofactor protein (CD46), decay accelerating factor ...

PubMed

5
Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method.
1994-11-01

Using an anti-receptor mAb that blocks the attachment of echovirus 7 and related viruses (echoviruses 13, 21, 29 and 33), we have isolated a complementary DNA clone that encodes the human decay-accelerating factor (CD55). Mouse cells transfected with the CD55 clone bind echovirus 7, and this binding is blocked by ...

PubMed Central

6
Decay Accelerating Factor (CD55)�Mediated Attenuation of Complement: Therapeutic Implications for Age-Related Macular Degeneration
2010-12-01

Purpose.Sequence variations in complement proteins are associated with age-related macular degeneration (AMD). The terminal pathway of complement results in the formation of the membrane attack complex (MAC) on the cell surface, resulting in their lysis. MAC has been documented on the retinal pigment epithelium (RPE), choroidal blood vessels, and drusen of AMD eyes. Here the investigators test the ...

PubMed Central

7
Identification of a human anti-CD55 single-chain Fv by subtractive panning of a phage library using tumor and nontumor cell lines.
1999-06-01

A large naive human single-chain (sc) Fv phage library was used to search for tumor-associated antigens by panning with a lung adenocarcinoma cell line, 1264, and counter-selecting with a nontumor bronchial epithelial cell line, BEAS-2B. After three rounds of subtractive panning, 239 of 673 clones analyzed bound selectively to 1264 tumor cells in a phage ELISA. Diversity analysis of these ...

PubMed

8
Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
1997-11-01

The membrane-bound complement regulators decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46), and CD59 are broadly expressed proteins that act together to protect host tissues from autologous complement. Comparison of expression profiles of these proteins between normal and pathological ...

PubMed Central

9
Combined Yeast ?-Glucan and Antitumor Monoclonal Antibody Therapy Requires C5a-Mediated Neutrophil Chemotaxis via Regulation of Decay-Accelerating Factor CD55
2007-08-01

Administration of a combination of yeast-derived ?-glucan with antitumor monoclonal antibodies (mAb) has significant therapeutic efficacy in a variety of syngeneic murine tumor models. We have now tested this strategy using human carcinomas implanted in immunocompromised severe combined immunodeficient mice. Combined immunotherapy was therapeutically effective in vivo against NCI-H23 human ...

PubMed Central

10
Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55).
2008-02-27

The Old World hantaviruses, members of the family Bunyaviridae, cause hemorrhagic fever with renal syndrome (HFRS). Transmission to humans occurs via inhalation of aerosols contaminated with the excreta of infected rodents. The viral antigen is detectable in dendritic cells, macrophages, lymphocytes, and, most importantly, microvascular endothelial cells. However, the site and detailed mechanism ...

PubMed

11
Differential Contributions of C3, C5 and Decay Accelerating Factor to Ethanol-induced Fatty Liver in Mice
2007-02-01

Background & Aims:The complement pathways are important components of the innate and adaptive immune response. Here we tested the hypothesis that activation of complement is required for development of ethanol-induced fatty liver.Methods:Wild type and mice lacking the 3rd (C3) and 5th (C5) components of the complement activation pathway, as well as ...

PubMed Central

12
Deletion of Decay-Accelerating Factor (CD55) Exacerbates Autoimmune Disease Development in MRL/lpr Mice
2002-09-01

Decay-accelerating factor (DAF, CD55) is a glycosylphosphatidylinositol-anchored membrane protein that restricts complement activation on autologous cells. It is also a ligand for CD97, an activation-associated lymphocyte antigen with seven transmembrane domains. It is widely expressed on cells of both the ...

PubMed Central

13
Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.
1994-06-21

Echoviruses are human pathogens belonging to the picornavirus family. Decay-accelerating factor (DAF) is a glycosylphosphatidylinositol (GPI)-anchored surface protein that protects cells from lysis by autologous complement. Anti-DAF monoclonal antibodies prevented echovirus 7 attachment to susceptible cells and protected cells from infection. HeLa cells ...

PubMed Central

14
Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli
2004-09-01

Decay-accelerating factor (DAF, CD55) is a glycophosphatidyl inositol-anchored glycoprotein that regulates the activity of C3 and C5 convertases. In addition to understanding the mechanism of complement inhibition by DAF through structural studies, there is also an interest in the possible therapeutic potential of ...

PubMed Central

15
Co-expression of alpha(1,3)galactosyltransferase and Bacillus thuringiensis PIPLC enhances hyperacute rejection of tumor cells.
2006-04-13

The use of alpha(1,3)galactosyltransferase (alphaGT) as a method of inducing hyperacute rejection of tumors has been gaining interest recently. However, the approach is based in part on the sensitivity of each tumor line to the effects of complement lysis. Tumors expressing complement resistance factors such as membrane cofactor (CD46), decay accelerating ...

PubMed

16
Cytokine-stimulated release of decay-accelerating factor (DAF; CD55) from HT-29 human intestinal epithelial cells
1998-09-01

Expression of DAF (CD55) is enhanced on colonic epithelial cells of patients with ulcerative colitis (UC), and stool DAF concentrations are increased in patients with active disease. Cytokines are known to modulate DAF expression in various human cells, and lesions of UC reveal altered profiles of cytokine production. In this study, we evaluate the effects ...

PubMed Central

17
Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.
1995-09-01

Various immune mechanisms have been reported to contribute to the progressive destruction of Th cells in HIV-1-infected patients. Among these, complement mediated lysis of infected cells has been suggested. An increased sensitivity of lymphocytes from HIV-1-infected patients to lysis by monoclonal antibodies directed to MHC class I antigen and complement has been directly correlated with a ...

PubMed Central

18
Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein.
2010-10-18

Vaccinia virus encodes a structural and functional homolog of human complement regulators named vaccinia virus complement control protein (VCP). This four-complement control protein domain containing secretory protein is known to inhibit complement activation by supporting the factor I-mediated inactivation of complement proteins, proteolytically cleaved form of C3 (C3b) and ...

PubMed

19
Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay.
2007-01-01

Decay-accelerating factor (DAF; CD55) inhibits the complement (C) cascade by dissociating the multimolecular C3 convertase enzymes central to amplification. We have previously demonstrated using surface plasmon resonance (Biacore International) that DAF mediates decay of the alternative pathway C3 convertase, ...

PubMed

20
Eculizumab for paroxysmal nocturnal haemoglobinuria.
2009-01-12

The complement system plays a central part in both innate and acquired immunity, but the contribution of complement activation to pathobiology is largely ancillary. An exception to the non-dominant role of complement in disease is the haemolytic anaemia of paroxysmal nocturnal haemoglobinuria (PNH). The intravascular haemolysis that is the clinical hallmark of PNH is a consequence of deficiency of ...

PubMed

First Page Previous Page 1 2 3 4 Next Page Last Page
 
First Page Previous Page 1 2 3 4 Next Page Last Page
 
21
Complement in organ transplantation
2010-08-01

Purpose of reviewThe aim of this review is to bring to attention the most recent advances made in understanding the role of complement components in both innate and adaptive immune responses in solid organ transplantation with emphasis on the kidney.Recent findingsAlongside recent findings related to the role of anaphylatoxins in modulating adaptive immune responses, there has been a genomic study ...

PubMed Central

22
Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection
2004-10-01

The assembly of respiratory syncytial virus (RSV) in lipid-rafts was examined in Hep2 cells. Confocal and electron microscopy showed that during RSV assembly, the cellular distribution of the complement regulatory proteins, decay accelerating factor (CD55) and CD59, changes and high levels of these cellular ...

Energy Citations Database

23
More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55).
2005-05-01

Swine vesicular disease virus (SVDV) evolved from coxsackie B virus serotype 5 (CVB5) in the recent past, crossing the species barrier from humans to pigs. Here, SVDV isolates from early and recent outbreaks have been compared for their capacity to utilize the progenitor virus receptors coxsackie-adenovirus receptor (CAR) and decay-accelerating factor ...

PubMed

24
The role of decay accelerating factor in the immunopathogenesis of cytomegalovirus infection.
2010-12-16

A wide variety of the host immune elements play an influential role in the defence against cytomegalovirus (CMV) infection. However, the role of complement in the clearance of CMV infection is less well studied. Decay accelerating factor (DAF/CD55) is a membrane-bound complement regulatory protein that inhibits the ...

PubMed

25
Dexamethasone modifies the susceptibility to serum cytotoxicity and increases the metastatic efficiency of a colon carcinoma cell line.
2005-12-27

Metastatic inefficiency is a phenomenon by which a majority of tumor cells is lost in the blood stream during the metastatic process. We investigated the effects of dexamethasone (DEX), a synthesized glucocorticoid, on the serum susceptibility of a colon carcinoma cell line, HT-29, with respect to metastatic inefficiency. The susceptibility to serum cytotoxicity of these carcinoma cells is ...

PubMed

26
Complement activation in Ghanaian children with severe Plasmodium falciparum malaria
2007-12-17

BackgroundSevere anaemia (SA), intravascular haemolysis (IVH) and respiratory distress (RD) are severe forms of Plasmodium falciparum malaria, with RD reported to be of prognostic importance in African children with malarial anaemia. Complement factors have been implicated in the mechanism leading to excess anaemia in acute P. falciparum infection.MethodsThe direct Coombs test ...

PubMed Central

27
Losac, a factor X activator from Lonomia obliqua bristle extract: Its role in the pathophysiological mechanisms and cell survival
2006-05-19

Contact with the bristles of the caterpillar Lonomia obliqua can cause serious hemorrhage. Previously it was reported that a procoagulant protein (Lopap) in the bristle extract of L. obliqua increases cell longevity by inhibiting apoptosis. In this work, we purified from bristle extract a factor X activator that stimulates proliferation of endothelial cells. This protein, ...

Energy Citations Database

28
Recognition of decay accelerating factor and alpha(v)beta(3) by inactivated hantaviruses: Toward the development of high-throughput screening flow cytometry assays.
2010-04-02

Hantaviruses cause two severe diseases in humans: hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS). The lack of vaccines or specific drugs to prevent or treat HFRS and HCPS and the requirement for conducting experiments in a biosafety level 3 laboratory (BSL-3) limit the ability to probe the mechanism of infection and disease pathogenesis. In this study, ...

PubMed

29
Sialic Acid Functions in Enterovirus 70 Binding and Infection
2002-11-01

The interaction of viruses with host cell receptors is the initial step in viral infection and is an important determinant of virus host range, tissue tropism, and pathogenesis. The complement regulatory protein decay-accelerating factor (DAF/CD55) is an attachment receptor for enterovirus 70 (EV70), a member of ...

PubMed Central

30
Resistance of ovarian teratocarcinoma cell spheroids to complement-mediated lysis.
1997-01-01

We have shown previously that it is possible to target complement-mediated killing against cultured ovarian tumour cells in vitro. As malignant ovarian cells usually grow in solid nodules in vivo, we have in the present study examined the effectiveness of complement killing against ovarian teratocarcinoma cells (PA-1) growing in three-dimensional tumour microspheroids (TMSs). Our study shows that ...

PubMed Central

31
Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack.
1995-05-01

CD59 is the major membrane attack complex of complement (MAC) inhibiting protein on human cells. Its regulation is therefore an important factor in determining the fate of cells at sites of complement activation. We have chosen the K562 erythroleukaemia cell line as a model for studies of the regulation of CD59 expression, because it has previously been reported that phorbol ...

PubMed Central

32
Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.
1991-12-01

The structural genes of human complement regulatory proteins are clustered on chromosome 1 at position q3.2. Human chromosome 1 was transferred into a mouse fibroblast cell line, A9 [designated as A9(neo-1)], and the surface expression of its gene products participating in complement regulation, namely C3b/C4b receptor (CR1, CD35), decay-accelerating ...

PubMed Central

33
Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.
2011-01-26

While group B coxsackieviruses (CVB) use the coxsackievirus and adenovirus receptor (CAR) as the receptor through which they infect susceptible cells, some CVB strains are known for their acquired capacity to bind other molecules. The CVB3/RD strain that emerged from a CVB3/Nancy population sequentially passaged in the CAR-poor RD cell line binds decay-accelerating ...

PubMed

34
Recognition of DAF and ?v?3 by inactivated Hantaviruses, towards the development of HTS flow cytometry assays
2010-04-02

Hantaviruses cause two severe diseases in humans: hemorrhagic fever with renal syndrome (HFRS) or hantavirus cardio-pulmonary syndrome (HCPS). The lack of vaccines or specific drugs to prevent or treat HFRS and HCPS, and the requirement for conducting experiments in a biosafety level 3 laboratory (BSL-3) limit the ability to probe the mechanism of infection and disease pathogenesis. In this study ...

PubMed Central

35
Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation.
2009-06-26

CD8 T cells primed by transplantation recognize allogeneic class I MHC molecules expressed on graft vascular endothelium and contribute to allograft injury. We previously showed that immune cell-derived complement activation fragments are integral to T cell activation/expansion. Herein we tested the impact of local complement production/activation on T cell/endothelial cell (EC) interactions. We ...

PubMed

36
High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers.
2011-05-18

Proteomic analysis of samples isolated by laser capture microdissection from clinical specimens requires sample preparation and fractionation methods suitable for small amounts of protein. Here we describe a streamlined filter-aided sample preparation (FASP) workflow that allows efficient analysis of lysates from low numbers of cells. Addition of carrier substances such as polyethylene glycol or ...

PubMed

37
Epithelial Invasion by Escherichia coli Bearing Dr Fimbriae Is Controlled by Nitric Oxide-Regulated Expression of CD55
2004-05-01

We previously reported that inhibition of nitric oxide (NO) increases the rate of bacteremia and maternal mortality in pregnant rats with uterine infection by Escherichia coli expressing the Dr fimbria (Dr+). Epithelial binding and invasion by Dr+ E. coli has also been shown to be dependent upon the expression level of the cellular receptor ...

PubMed Central

38
Early expression changes of complement regulatory proteins and C5A receptor (CD88) on leukocytes after multiple injury in humans.
2010-06-01

As a crucial element of innate immunity, the complement cascade becomes activated after severe trauma. Regulation of the complement cascade and protection against complement-mediated tissue destruction is provided by a selection of soluble and membrane-bound complement regulatory proteins (CRegs). To date, the leukocyte expression profile of CRegs in multiple injured patients is unknown. In the ...

PubMed

39
Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion
1999-06-01

The aetiopathogenesis of chronic otitis media with effusion (OME) in children is not yet fully understood. OME is characterized by metaplasia of the epithelium and accumulation of sticky, glue-like effusion in the middle ear containing different mediators of inflammation, including activation fragments of the complement system. Here we examined whether the fluid phase complement activation is ...

PubMed Central

40
Binding of GPI-PLD-treated DAF to the surface of Schistosoma mansoni schistosomula.
1994-02-01

Decay accelerating factor (DAF,CD55) is a 70-kDa glycosylphosphatidylinositol (GPI)-anchored protein that protects human erythrocytes (HuE) from complement-mediated damage by regulation of the C3-convertase. Purified human DAF can be incorporated into sheep red blood cell (SRBC) membrane and confer complement ...

PubMed

First Page Previous Page 1 2 3 4 Next Page Last Page
 
First Page Previous Page 1 2 3 4 Next Page Last Page
 
41
Reduction of Incremental Load Factor Acceleration Data to ...
1994-08-01

... 5. Report Date Reduction of Incremental Load Factor Acceleration Data to August 1994 Gust Statistics ... ACCELERATION _____ _____ ...

DTIC Science & Technology

42
Up-Regulation of Intestinal Vascular Endothelial Growth Factor by Afa/Dr Diffusely Adhering Escherichia coli
2007-12-26

BackgroundAngiogenesis has been recently described as a novel component of inflammatory bowel disease pathogenesis. The level of vascular endothelial growth factor (VEGF) has been found increased in Crohn's disease and ulcerative colitis mucosa. To question whether a pro-inflammatory Escherichia coli could regulate the expression of VEGF in human intestinal epithelial cells, ...

PubMed Central

43
The structure of complement C3b provides insights into complement activation and regulation.
2006-10-15

The human complement system is an important component of innate immunity. Complement-derived products mediate functions contributing to pathogen killing and elimination. However, inappropriate activation of the system contributes to the pathogenesis of immunological and inflammatory diseases. Complement component 3 (C3) occupies a central position because of the manifold biological activities of ...

PubMed

44
Effect of periodontopathogen lipopolysaccharides and proinflammatory cytokines on CD46, CD55, and CD59 gene/protein expression by oral epithelial cells.
2011-06-08

Membrane-anchored complement regulatory proteins (CRPs), including CD46, CD55, and CD59, protect host cells from complement attack. In the present study, we investigated whether periodontopathogen lipopolysaccharide and proinflammatory cytokines modulate CRP gene/protein expression in human oral epithelial cells. The lipopolysaccharide of Treponema ...

PubMed

45
Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
1991-01-01

The isoform of Fc gamma RIII (CD16) expressed on PMN has a GPI membrane anchor, and in paroxysmal nocturnal hemoglobinuria (PNH) there is a deficiency in Fc gamma RIII expression on PMN. Contrary to expectation, however, CD16 expression is preserved (albeit at reduced levels) in all affected PNH PMN that completely lack the GPI-anchored proteins DAF (CD55) ...

PubMed Central

46
Hemolysis Is Associated with Low Reticulocyte Production Index and Predicts Blood Transfusion in Severe Malarial Anemia
2010-04-06

BackgroundFalciparum Malaria, an infectious disease caused by the apicomplexan parasite Plasmodium falciparum, is among the leading causes of death and morbidity attributable to infectious diseases worldwide. In Gabon, Central Africa, one out of four inpatients have severe malarial anemia (SMA), a life-threatening complication if left untreated. Emerging drug resistant parasites might aggravate ...

PubMed Central

47
Accelerated response of thermopile pyranometers
1976-01-01

Tests with a compensating network show that the response of a thermopile pyranometer can be accelerated by a factor of about ten.

Energy Citations Database

48
VOLTAGE ACCELERATION FACTOR VS. LONGEVITY AND ...
1974-04-14

... Title : VOLTAGE ACCELERATION FACTOR VS. LONGEVITY AND CORONA DISCHARGES OF MICA CAPACITORS. Corporate Author : ...

DTIC Science & Technology

49
Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury
2010-04-09

BackgroundActivated complement system is known to mediate neuroinflammation and neurodegeneration following exposure to hypoxic-ischemic insults. Therefore, inhibition of the complement activation cascade may represent a potential therapeutic strategy for the management of ischemic brain injury. Decay-accelerating factor (DAF, also known as CD55) inhibits ...

PubMed Central

50
ANALYSIS OF EXPOSURE FACTORS INFLUENCING THE ...
1973-06-01

... Title : ANALYSIS OF EXPOSURE FACTORS INFLUENCING THE IMAGE QUALITY IN LINEAR ACCELERATOR RADIOGRAPHY. ...

DTIC Science & Technology

51
THE THEORY OF A PLASMA ACCELERATION PROCESS ...
1960-02-15

... ACCELERATION PROCESS SUITABLE FOR SPACE PROPULSION AND FUSION INJECTION ... factors (the ratio of the directed kinetic energy to the ...

DTIC Science & Technology

52
Outdoor and Accelerated Weathering of Elastomers and ...
1972-03-01

... the many factors in the weather which contribute ... specimens cut from the weathered sheets of ... during exposure to accelerated weathering cycles in ...

DTIC Science & Technology

53
Investigation of reliability attributes and accelerated stress factors on terrestrial solar cells
1979-01-01

The results of accelerated stress testing of four different types of silicon terrestrial solar cells

NASA Technical Reports Server (NTRS)

54
Accelerators for the Organic Peroxide Curing of Polyesters ...
1968-02-06

... Accession Number : ADD424696. Title : Accelerators for the Organic Peroxide Curing of Polyesters and Factors Influencing their Behavior,. ...

DTIC Science & Technology

55
ACCELERATED LIFE TESTING OF METALLIC RECTIFIERS
1953-03-31

... ACCELERATED LIFE TESTING OF METALLIC RECTIFIERS ... FACTORS AFFECTING LIFE CHARACTERISTICS CF METALLIC RECTIFIERS ...

DTIC Science & Technology

56
Optimum acceleration factors for iterative solutions of linear ...
1988-05-15

... Accession Number : ADA198408. Title : Optimum acceleration factors for iterative solutions of linear and non-linear systems. ...

DTIC Science & Technology

57
Human Recombinant Decay-Accelerating Factor (DAF) ...
2008-12-01

... Accelerating Factor (DAF) Increases Survival and Limits Tissue Injury After ... Hemorrhagic blood loss or resuscitation following hemorrhage leads to ...

DTIC Science & Technology

58
Factors Affecting Human Tolerance to Sustained Acceleration
1983-11-30

Page 1. REPORT NO. NADC-84021-60 FACTORS AFFECTING HUMAN TOLERANCE TO SUSTAINED ACCELERATION Leonid Hrebien, Ph. ...

DTIC Science & Technology

59
Factors Affecting Human Tolerance to Sustained Acceleration
1983-11-30

... Accession Number : ADA138520. Title : Factors Affecting Human Tolerance to Sustained Acceleration. Descriptive Note : Interim rept. ...

DTIC Science & Technology

60
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.
2011-07-01

We evaluated the expression of tissue factor (TF) in ovarian cancer (EOC) and the potential of hI-con1, an antibody-like molecule targeting TF, as a novel form of therapy against chemotherapy-resistant ovarian disease. We studied the expression of TF in 88 EOC by immunohistochemistry (IHC) and real-time-PCR (qRT-PCR) and the levels of ...

PubMed

First Page Previous Page 1 2 3 4 Next Page Last Page
 
First Page Previous Page 1 2 3 4 Next Page Last Page
 
61
Crystallization and preliminary X-ray diffraction analysis of three EGF domains of EMR2, a 7TM immune-system molecule.
2004-04-21

Crystals of three epidermal growth-factor-like (EGF) domains of EMR2 (143 residues) have been grown. EMR2 is a member of the EGF-TM7 family of proteins. Different splice variants exist with between three and five consecutive EGF modules linked to a seven-span transmembrane G-protein-coupled receptor. Although its precise function is unknown, EMR2 is highly expressed in immune ...

PubMed

62
Clinical pig liver xenotransplantation: how far do we have to go?

As pigs are currently the preferred species for organ xenotransplantation, initial experience in liver xenotransplantation with wild-type (WT) pigs, advances in the development of genetically modified pigs, and recent studies using livers from them are reviewed. The xenotransplantation of livers from pigs transgenic for the human complement regulatory protein (CRP) ...

PubMed

63
Energy Efficiency of Laser Driven, Structure Based Accelerators
2004-04-21

The acceleration efficiency of a laser driven linear accelerator is analyzed. The laser power, loss factor and impedances determine the maximum charge that can be accelerated and the efficiency of that acceleration. The accelerator structure can be incorporated into a laser ...

DOE Information Bridge

64
Investigation of the electrodynamic characteristics of MHD accelerators
1979-09-01

Results are presented of experimental investigations of the volt--ampere charactaeristics of a discharge between the electrodes of an MHD accelerator, of the longitudinal boundary effect, the Hall voltage on different components of the accelerator, etc. The results obtained are numerically analyzed and the main factors determining the ...

Energy Citations Database

65
The Future of the Russian Military: Constraints, Trends, and ...
1993-03-03

... of the Russian Military: Constraints, Trends, and Factors Affecting Stability and ... by accelerating the development of those positive factors identified ...

DTIC Science & Technology

66
Human Factors Considerations in High Performance Aircraft ...
1984-11-01

... MILITARY AIRCRAFT, *HUMAN FACTORS ENGINEERING, *MAN ... MISSIONS, USER NEEDS, WORKLOAD, ESCAPE SYSTEMS, ACCELERATION ...

DTIC Science & Technology

67
Thresholds for the Perception of Angular Acceleration as ...
1973-06-11

... canals and a knowledge of cupuloendolymph mechanisms, the role of adaptation effects and the influence of secondary etiological factors are all ...

DTIC Science & Technology

68
Therapeutic Administration of Recombinant Human ...
2011-05-15

... Therapeutic Administrati in of Recombinant Human Granulocyte Colony- Stimulating Factor Accelerates Hemopoietic Regeneration and Enhances ...

DTIC Science & Technology

69
THE INVESTIGATION OF THE PARAMETERS OF HEAD ...
1965-05-31

... This would indicate that factors other than accelerations of the magnitudes, waveshape and directions used here are contributory to concussion. ...

DTIC Science & Technology

70
Subcellular Responses to Narrowband and Wideband ...
2008-02-15

... d.2. PLATELET AGGREGATION AND GROWTH FACTOR RELEASE: A STEP TOWARDS ACCELERATED WOUND HEALING ...

DTIC Science & Technology

71
EFFECT OF POSITIVE PRESSURE BREATHING ON THE ...
1961-08-01

... Abstract : The main factors limiting tolerance to forward acceleration are dyspnea, chest pain, and difficulty in inspiring. ...

DTIC Science & Technology

First Page Previous Page 1 2 3 4 Next Page Last Page